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In many mammalian species, more than half of the initial oocyte population is eliminated by neonatal
life, thus limiting the oocyte reserve for reproduction. The cause or mechanism of this major oocyte loss
remains poorly understood. We examined the apoptotic pathway involved in oocyte elimination in
wild-type mouse ovaries as well as inMsh5 / ovaries, in which all oocytes were eliminated due to a
lack of double strand break repair. Immunoblot and immunoﬂuorescence staining showed that an
initiator caspase 9 and an effector caspase 7 were constitutively activated in almost all oocytes in fetal
ovaries regardless of their genotypes. In caspase 9 / ovaries, the total number of oocytes remained
high while that in wild-type ovaries steadily declined during ovarian development. Therefore, the
activation of caspase 9 was required for but did not immediately lead to oocyte demise. We found that
XIAP, an endogenous inhibitor of apoptosis, was also abundant in oocytes during meiotic prophase
progression. On the other hand, a cleaved form of PARP1, a target of effector caspases, was localized to
the nuclei of a limited number of oocytes, and the frequency of cleaved PARP1-positive oocyte nuclei
increased signiﬁcantly higher before all oocytes disappeared in Msh5 / ovaries. We conclude that
the mitochondrial apoptotic pathway mediated by caspase 9 is constitutively activated in oocytes and
renders the elimination of oocytes with meiotic errors, which can be captured by the cleavage of PARP1.
& 2013 Elsevier Inc. All rights reserved.Introduction
Women are born with ﬁnite numbers of oocytes, thus limiting
their reproductive life span. It is dogma that a female fetus starts
with a large number of oocytes but loses as many as 70% of them
before birth (Baker, 1963). The physiological role or cause of this
massive oocyte loss remains unknown. A few hypotheses have been
forwarded, mainly based on the studies in mice (reviewed by Tilly
(2001)). One attractive hypothesis assumes that the oocytes with
meiotic errors are eliminated by a checkpoint mechanism, con-
tributing to the quality control of surviving oocytes. This hypothesis
was originally proposed based on the morphological observations
that a degeneration of oocytes is often seen around the pachytene
stage, when homologous chromosomes complete pairing and
recombination (Dietrich and Mulder, 1983; Beaumont and Mandl,
1962; Speed, 1988; Borum, 1961). This hypothesis was furtherll rights reserved.
ry, Royal Victoria Hospital,
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o).
le.supported by the ﬁndings that various mutations, which impair
meiotic synapses or recombination, result in an excessive oocyte
loss by the end of meiotic prophase progression (reviewed by
Cohen et al. (2006)). The pachytene checkpoint has been proposed
in yeast and adapted to mammalian spermatogenesis (Ashley et al.,
2004; Bailis and Roeder, 2000). However, it remains to be clariﬁed
how the checkpoint mechanism is activated in oocytes and leads to
their demise.
Of three main mechanisms of cell death, necrosis, autophagy,
and apoptosis, apoptosis has been implicated in oocyte death
under physiological conditions although the role of autophagy has
not yet been completely ruled out (De Felici, 2005; Morita and
Tilly, 1999; Rodrigues et al., 2009). The signaling molecules
involved in the apoptotic pathway of oocytes, particularly during
meiotic prophase progression, remain to be identiﬁed. Two main
apoptotic pathways, intrinsic and extrinsic pathways, are known
to operate in mammalian cells (Thress et al., 1999; Los et al.,
1999). The intrinsic pathway is triggered by various extracellular
and intracellular stresses, such as growth factor withdrawal and
DNA damage, and involves the release of cytochrome c from
the mitochondria into the cytosol. The free cytochrome c binds
to Apoptotic Protease-Activating Factor-1 (APAF-1), which then
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named apoptosome, results in the activation of caspase 9 and the
subsequent activation of effector caspases 3, 6, and/or 7. The active
effector caspases in turn cleave a set of proteins, including poly-ADP
ribose polymerase-1 (PARP1), causing the morphological changes
typical of apoptosis. Caspase 2 has the molecular characteristics of
an initiator caspase and can be activated by DNA damage upstream
of the mitochondria pathway (Robertson et al., 2002). It can also be
activated by other caspases (Slee et al., 1999). Members of the Bcl-2
family of proteins play a major role in governing the mitochondrial
apoptotic pathway, with proteins such as Bad and Bax functioning
as apoptosis inducers and Bcl-2 and Bcl-x as suppressors. The
extrinsic pathway is activated by the binding of ligands such as
Fas to death receptors on the cell membrane. This binding recruits
a ligand-speciﬁc death domain, which in turn activates initiator
caspase 8 or 10 and subsequent apoptotic events. The intrinsic and
extrinsic pathways may cross talk to amplify apoptotic signals. For
example, activated caspase 8 can initiate the mitochondrial apoptotic
pathway by the cleavage of Bid. On the other hand, caspase 8 can
also be activated downstream of caspase 9 (Kruidering and Evan,
2000; Viswanath et al., 2001).
Targeted null mutations of apoptosis-related molecules pro-
vided important but incomplete information about oocyte loss.
The deﬁciency in antiapoptotic molecules, Bcl-2 and Bcl-x, results in
a marked reduction in the number of primordial follicles in
neonatal ovaries (Ratts et al., 1995; Rucker et al., 2000). Further-
more, a null mutation of caspase 2 increases the number of
primordial follicles (Flaws et al., 2001; Bergeron et al., 1998). On
the other hand, no change was found when caspase 3, a key
proapoptotic molecule, was absent (Matikainen et al., 2001). The
consequence of Bax deﬁciency has been controversial; Perez et al.
(1999) found no change, whereas we found a signiﬁcant increase in
the number of oocytes in neonatal ovaries (Alton and Taketo, 2007).
Unfortunately, most above cases were examined only after birth.
Since female germ cells are lost continuously while they go through
mitosis and then various stages of meiotic prophase (McClellan
et al., 2003), different apoptotic pathways may operate for the
elimination of germ cells at different stages. Indeed, we have shown
that oogonia are lost by a BAX-dependent apoptotic pathway
whereas oocytes are lost during meiotic prophase progression in a
BAX-independent mechanism (Alton and Taketo, 2007). Therefore,
twice number of oocytes in the Bax deﬁcient ovary after birth can
be attributed to the suppression of the apoptotic death of oogonia,
but not of oocytes. Thus, more studies are needed for clarifying the
role of apoptosis in oocyte elimination.
In the present study, we examined the apoptotic pathway
involved in the elimination of oocytes in fetal and neonatal wild-
type mouse ovaries, as well as those deﬁcient inMsh5 as a model for
meiotic errors. MSH5 is a member of the DNA mismatch repair
protein family and plays a speciﬁc role in meiosis, in the repair of
double strand breaks (DSBs) imposed at the onset of meiosis and in
the consequent meiotic recombination (Edelmann et al., 1999).
Therefore, in the absence of MSH5, DSBs remain unrepaired, resulting
in excessive asynapses and oocyte loss (De Vries et al., 1999;
Edelmann et al., 1999; Di Giacomo et al., 2005). We assumed that
the excessive loss of oocytes with meiotic errors might reﬂect in
changes of the apoptotic signaling pathway responsible for oocyte
elimination.Materials and methods
Animals
All animal procedures were performed in accordance with the
Canadian Council on Animal Care and approved by the McGillUniversity Animal Care Committee. Msh5 and Casp9 null mutant
carrier mice have been generated (Edelmann et al., 1999; Hakem
et al., 1998) and maintained on the C57BL/6J (B6) genetic back-
ground in our mouse colony. B6 mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). Heterozygous mutant males
and females were crossed to generate Msh5 or Casp9 wild-type
(þ/þ), heterozygous mutant (þ/), and homozygous mutant
(/) progeny. The gestation age was deﬁned as days postcoi-
tum (dpc), assuming that copulation occurred at midnight.
Delivery usually occurs at 19.5 dpc; however, we used dpc to
specify postnatal ages for consistency. When ovaries were iso-
lated, a piece of liver was also removed from each mouse, and
used for genotyping by PCR ampliﬁcation either directly (for
Msh5) or after DNA isolation (for Casp9). PCR ampliﬁcation
included initial denaturation at 95 1C for 10 min, 35 cycles of
denaturation at 95 1C for 30 s, annealing at 55 1C for 30 s, and
extension at 72 1C for 1 min, followed by ﬁnal extension at 72 1C
for 15 min using a thermocycler (Whatman Biometra, Goettingen,
UK). The amplicons were analyzed by 2% agarose gel electrophor-
esis with ethidium bromide staining. Three primers, A, AGACC-
TGCACTGCGAGATCCG, B, TGGAAGGATTGGAGCTACGG, and C,
TCTCGAATAGCCGTAGTCCCG were used for Msh5 genotyping
in early studies. The primers A and C ampliﬁed the wild type
(approximately 300 bp) allele while the primers A and B ampliﬁed
the mutant (approximately 400 bp) allele. However, these pri-
mers did not allow simultaneous ampliﬁcation of both alleles due
to sequence overlapping. Accordingly, we redesigned the primers
A0, AGGAGCCCGTGGTAGGAG and C0, CCATGGATACAGGGAGAG-
TAATG to replace A and C in later studies. The results were
consistent when both methods were applied to the same samples.
For Caps9 genotyping, we used primers CTTTGTCCCTCCTG-
TTGTGTCTTCA and CAGAGCGAGAATGAAGGGGAAACAA for detect-
ing the wild-type allele (approximately 400 bp) and primers
CTTATGTATTCCCGAGCCCGTGGTA and GTATGCTATACGAAGTTAT-
TAGTCC for detecting the mutant allele (approximately 600 bp).
Histology preparations
Ovaries were isolated from fetuses or newborns, and ﬁxed and
embedded in parafﬁn as previously described (Taketo et al.,
2005). Serial sections of 5 mm thickness were collected and used
for IF staining.
Dissociated ovarian cell preparations
Immediately after isolation, ovaries without mesonephroi
were dissociated, treated with a hypotonic solution (0.5% NaCl,
pH 8.2), and spun down onto histology slides as previously
described (Alton and Taketo, 2007; Taketo, 2012). The slides were
kept in a sealed box containing desiccators at 20 1C until use.
Immunoﬂuorescence (IF) staining
Ovarian sections on histology slides were deparafﬁnized and
subjected to antigen retrieval as previously described (Taketo
et al., 2005). Dissociated cell preparations on histology slides
were directly processed for IF staining. All slides were incubated
with primary antibodies overnight at either room temperature or
4 1C, incubated with secondary antibodies conjugated with either
biotin or ﬂuorescence dyes, and incubated with avidin conjugated
with ﬂuorescence dyes of different color. Primary antibodies,
secondary antibodies, and avidin-conjugates together with their
sources and concentrations are given in Supplemental Table S1.
The rat monoclonal antibody against GCNA1 and the mouse or
rabbit polyclonal antibody against synaptonemal complex pro-
teins (SC) were gifts from Drs. Enders (Enders and May, 1994) and
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purchased from AbCam (Cambridge, MA), Santa Cruz Biotechnol-
ogy (Santa Cruz, CA), Cell Signaling Technology (Danvers, MA),
Imgenex (San Diego, CA), Pierce Endogen (Rockford, IL), Novus
Biologicals (Littleton, CO), Vector (Burlingame, CA), and Molecular
Probes (Eugene, OR). After IF staining, the slides were air-dried
and mounted in the Prolong Antifade mounting medium (Mole-
cular Probe) containing 1.0 mg/ml 40,6-diamidin-20-phenylindole
dihydrochloride (DAPI) (Roche Diagnostics, Mannheim, Germany).
Fluorescent signals were examined under an epiﬂuorescence micro-
scope (Zeiss Axiophot, Germany). All images were captured with a
digital camera (Retiga 1300, QImaging, Burnaby, BC) and processed
with Northern Eclipse digital imaging software, version 6.0 (Empix
Imaging, Mississauga, ON). No distinct signals were seen when the
primary antibodies were omitted (negative control).Fig. 1. The total number of GCNA1-positive cells in Msh5 / ovaries compared
to the control (þ/þ and þ/) ovaries at progressive developmental stages. Each
value indicates the mean7s.e.m. The number of examined ovaries is shown near
the s.e.m. nSigniﬁcant difference (Po0.05) compared to the control.Immunoblot
All chemicals and equipment for electrophoresis and transfer
were purchased from Bio-Rad (Mississauga, ON) unless speciﬁed.
Each pair of fetal ovaries was snap-frozen in a microfuge tube and
stored at 80 1C. Each sample was lysed in 15 or 20 ml sample
buffer containing dithiothreitol by repeating freezing and thawing
until no more tissue chunks were visible, followed by boiling for
10 min, vortex-mixing, and centrifugation. Some ovaries were
stored in sample buffer at 80 1C before lysis. The supernatant of
each sample and a broad-range biotinylated molecular weight
standard mix as well as controls (Jurkat cells with or without
treatment with etoposide, Cell Signaling Technology) were loaded
on 15% or 4–15% gradient bis-polyacrylamide gel containing SDS.
The proteins after fractionation in SDS-PAGE were transferred
electrophoretically to 0.45 mm nitrocellulose membranes in Tris–
glycine buffer containing 20% methanol by using a Trans-Blot Cell
apparatus. The membranes were blocked with 5% skim milk and
incubated with the primary antibody, followed by the secondary
antibody conjugated with biotin. The primary antibodies used,
their sources, and concentrations are given in Supplemental Table
S1. The membranes were then incubated with a donkey anti-
rabbit antibody conjugated with biotin (Jackson ImmunoRe-
search, Mississauga, OT) at 1:5.000 dilutions, followed by a goat
anti-biotin antibody conjugated with horseradish peroxidase
(HRP) at 1:500 dilutions. The enzymatic activity of HRP was detected
with Lumi-Light ECL kit (Roche Diagnostics). The bands were
digitized by using an Agfa Snapscan 1236 scanner (Agfa-Gevaert,
NV) and analyzed with the Un-Scan-It gel software version 5.1 (Silk
Scientiﬁc, Orem. UT).
RT-PCR
Total RNA was isolated from each ovary using the micro-
RNeasy kit (Quiagen, Mississauga, ON) including DNase I diges-
tion and eluted in 14 ml water, 10 ml of which was subjected to
ﬁrst strand cDNA synthesis with random hexamers and Super-
script III according to the manufacturer’s instruction (Invitrogen
Life Technologies, Burlington, ON). cIAP1, cIAP2, XIAP, and Survivin
were ampliﬁed by adding 2 ml cDNA aliquot and primers in a total
50 ml reaction mixture as previously reported (Kawamura et al.,
2003) for 30 cycles.
Statistical analyses
The total number of germ cells was counted in each ovary from
at least three females and two litters, unless speciﬁed, and the
mean and standard errors of the mean (SEM) was calculated in
each group. The percentages of meiotic substages were estimatedby counting over 100 GCNA1-positive cells per ovary. For double
staining of GCNA1 and cPARP1 in each dissociated cell prepara-
tion, at least 100 GCNA1-positive cells were identiﬁed and its
staining with cPARP1 was recorded. Only those with GCNA1 and
DAPI staining were considered as oocyte nuclei. Immnoblots were
repeated starting from separate pairs of ovaries. Signiﬁcant
difference between groups was estimated by Student’s t-test,
ANOVA, or regression analysis.Results
The loss of germ cells in fetal and neonatal Msh5 mutant ovaries
We ﬁrst compared the changes in the total number of germ
cells (i.e., oogonia and oocytes) between Msh5 þ/þ , þ/ , and
/ ovaries during development. We identiﬁed the germ cells in
dissociated cell preparations of each ovary by IF staining for
GCNA1 (Enders and May, 1994). The numbers of GCNA1-positive
cells in Msh5 þ/þ and þ/ ovaries were not different and
pooled as the control. The numbers in Msh5 / ovaries were
consistently lower than those in the control ovaries from 17.5 dpc
onwards, but reached signiﬁcant differences (Po0.05) at 19.5 and
20.5 dpc (Fig. 1). The overall rate of germ cell loss (i.e., the slope)
was similar between Msh5 / and the control ovaries. We did
not count the number of germ cells beyond 20.5 dpc because
GCNA1 expression ceased at mid diplotene stage (Alton and
Taketo, 2007). We conﬁrmed that very few germ cells were
identiﬁed by IF staining for Mouse Vasa Homolog (MVH), a
cytoplasmic maker for germ cells (Toyooka et al., 2000), in the
histological sections of Msh5 / ovaries at 22.5 dpc (not shown).
Meiotic prophase progression in Msh5  / ovaries
Next, we compared meiotic prophase progression in the
dissociated cell preparations ofMsh5 / and the control ovaries
by double IF staining for SC and g-H2AX (Fig. 2A). We introduced
IF staining for g-H2AX because the zygotene and early diplotene
stages or the leptotene and late diplotene stages were often
difﬁcult to distinguish by SC staining alone. In the control ovaries,
g-H2AX staining was seen in the entire nucleus at the leptotene
and zygotene stages and largely disappeared by the mid pachy-
tene stage (Fig. 2Aa–g). g-H2AX staining remained in several foci
in some early pachytene oocytes or along one or a few SC cores,
probably associated with persistent asynapses, in pachytene and
diplotene oocytes (Fig. 2Ad); however, these staining patterns
Fig. 2. Meiotic prophase progression in oocytes during ovarian development. A. Typical IF staining for SC (red) and gH2AX (green) in the oocytes fromMsh5 þ/þ (a–g) and
Msh5 / (h–k) ovaries. Bar 40 mm. a. Early zygotene. Partial thickening of SC is seen while the entire nucleus is labeled for gH2AX. b. Mid zygotene. SC cores are further
thickened and shortened. c. Late zygotene-early pachytene. The intensity of gH2AX staining decreased. d. Early pachytene. The staining for gH2AX has disappeared except
for a few foci or intense staining along a SC core (arrowhead), which likely harbors persistent asynapsis. e. Mid pachytene. Discrete 20 SC cores are seen. f. Mid diplotene.
Most homologous chromosomes are dissociated except for crossovers. g. Late diplotene. SC cores are thinner and fragmented. h. Similar to early zygotene (a). i. Similar to
mid zygotene (b). j. Zygotene-like. Most chromosomes remain asynapsed and the entire nucleus is labeled for gH2AX like zygotene. However, chromosomes are spread
into a large area more like pachytene. k. Late diplotene-like. SC cores are faint and fragmented like the normal late diplotene (g). However, the entire nucleus is labeled for
gH2AX. Therefore, this nucleus can be categorized as early zygotene except for the large size. B. Percentage of SC-positive oocytes at progressive meiotic stages from the
control and Msh5 / ovaries. The number of examined ovaries is given on the top of each column.
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criteria, the meiotic prophase was found to have progressed
steadily from the zygotene to diplotene stage in the control
ovaries from 16.5 to 20.5 dpc (Fig. 2B). These deﬁnitions of
meiotic prophase stages could not simply be applied to Msh5
/ ovaries. Typical leptotene and zygotene oocytes were
observed (Fig. 2Ah and i). However, based on the above deﬁnition,
the majority of oocytes remained at the zygotene stage, showing
incomplete synapses and heavy g-H2AX staining, from 16.5
through 20.5 dpc (Fig. 2Aj and k). These oocytes could have been
at the pachytene stage with extensive asynapses or the diplotene
stage with persistent g-H2AX staining. A small number of oocytes
appeared to be pachytene with faint or no g-H2AX staining; but
they all had excessive number of SC cores (not shown).Cleavage of caspases detected by immunoblots of ovaries
To identify the apoptotic pathway involved in oocyte elimina-
tion, we examined the cleavage (activation) of various caspases in
Msh5 þ/þ and / ovaries at 16.5–19.5 dpc by immunoblots
(Fig. 3). The results indicated a robust increase in the activation of
caspase 9 with a peak at 18.5 dpc in both genotypes of ovaries.
The antibody from Cell Signaling detected the procaspase 9 at
49 kDa and its cleaved forms at 37 and 39 kDa (Fig. 3A). We
calculated the ratio of band intensities at 37 kDa vs. 49 kDa in
each lane as the activation level, which reached about 1:1 on
average at 18.5 dpc. The antibody from Imgenex detected only the
cleaved forms at 15 and 35 kDa (Fig. 3A) and, therefore, could not
be used for the calculation of activation levels, although results
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contrast, the activation of caspases 7 (Fig. 3B), 2 and 6 (not
shown) remained minimal and that of caspase 3 was undetectable
although their full forms were easily detectable at all examined
stages. No signiﬁcant difference in the activation levels was found
between Msh5 þ/þ and / ovaries for all caspases and
developmental stages examined.
IF localization of cleaved caspases in ovarian sections
Excessive activation of apoptotic pathway inMsh5 / oocytes,
even if it occurred, might not have been reﬂected into the
immunoblot of entire ovaries. To examine the activation of caspases
in the oocyte, we performed IF staining of ovarian sections with theFig. 3. Cleavage of caspases 7 and 9 inMsh5 þ/þ and / ovaries during fetal develop
49 kDa procaspase 9 and its 37 and 39 kDa cleaved forms (top) while the antibody fro
was calculated by the ratio of 37 kDa to 49 kDa band intensities (bottom). Three sets of
Each column indicates the mean7s.e.m. B. Immunoblot of caspase 7. The antibody reco
and the positive control (C, human Jurkat cells treated with etoposide) but not in the
activation level was calculated by the ratio of 16 kDa to 35 kDa band intensities (bottom
Each column indicates the mean7s.e.m.
Fig. 4. IF localization of cleaved caspase 9 in histological sections of Msh5 þ/þ ovarie
merged with DAPI counterstaining (blue) in a–d, followed by green and red signals alon
the same site of the section. The cleaved caspase 9 is distributed evenly in the cytoplasm
At 18.5 dpc. The staining for cleaved caspase 9 is intense in the cytoplasm of some ooantibody which speciﬁcally recognized the cleaved forms of caspase
9. With the antibody from Imgenex, homogeneous ﬂuorescence
staining was seen in the cytoplasm of almost all oocytes in Msh5
þ/þ ovaries at 16.5 dpc (Fig. 4a and b). At 18.5 dpc, the intensity of
IF staining increased in some oocytes while it decreased in others
(Fig. 4c and d). Faint IF staining was visible in somatic cells near
oocytes but was absent in the area devoid of oocytes. Similar
localization of cleaved caspase 9 was seen with the antibody from
Cell Signaling or inMsh5 / ovaries (not shown). IF staining with
the antibody which recognized the 20 kDa fragment of caspase
7 also showed a similar localization to cleaved caspase 9 in Msh5
þ/þ ovaries (Fig. S1), as well as in Msh5 / ovaries (not shown).
No remarkable IF staining was seen with the antibody which
recognized the 17/19 kDa fragments of caspase 3 (not shown).ment. A. Immunoblot of caspase 9. The antibody from Cell Signaling recognized the
m Imergen recognized 35 and 15 kDa cleaved forms (middle). The activation level
ovaries were examined at each developmental stage except for one set at 16.5 dpc.
gnized the 35 kDa procaspase 7 and its 16 kDa cleaved form in both ovarian lysate
negative control (NC, human Jurkat cells without apoptosis induction) (top). The
). 2, 3, and 3 sets of ovaries were examined at 16.5, 18.5, and 19.5 dpc, respectively.
s. IF staining for the 15/35 kDa fragments of caspase 9 (red) and GCNA1 (green) is
e. Bar 160 mm in a, c and 40 mm in b, d. a and b. At 16.5 dpc. The asterisk indicates
of almost all oocytes. Yellow signals are autoﬂuorescence in blood cells. c and d.
cytes.
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staining over the background level.
Oocyte retention in caspase 9  / ovaries
To test whether activation of caspase 9 plays a role in oocyte
elimination, we examined the total number of GCNA1-positive
cells in Caspase 9 (Casp9) þ/þ , þ/ , and / ovaries at 16.5–
19.5 dpc. As previously reported, the survival of Casp9 /
fetuses decreased rapidly during this period (Hakem et al.,
1998; Kuida et al., 1998). Nonetheless, we obtained a small
number of Casp9 / female progeny up to 19.5 dpc. The
number of GCNA1-positive cells in Casp9 / ovaries was
comparable with that in Casp9 þ/þ ovaries at 16.5 and
18.5 dpc (Fig. 5A). However, the overall loss of oocytes during
ovarian development in Casp9 / ovaries from 16.5 to 19.5 dpc
(r¼0.34552) was much slower than that in Casp9 þ/þ ovaries
(r¼0.95378) with a signiﬁcant difference (Po0.001) (Fig. 5B).
Consequently, the total number of GCNA1-positive cells in Casp9
/ ovaries became twice as large as that in Casp9 þ/þ ovaries
at 19.5 dpc (Fig. 5A).
Next, we examined at which stage the excessive number of
oocytes were accumulated in Casp9 / ovaries. According to
double staining of GCNA1 and SC in dissociated ovarian cells,
typical zygotene and pachytene oocytes were seen at 16.5 and
18.5 dpc, and the vast majority were at the diplotene-like stage at
19.5 dpc (not shown). However, we could not rule out the
possibility that the latter cells were actually at the leptotene or
early zygotene stages by SC staining alone. To verify meiotic
progression in Casp9 / ovaries, we performed IF staining for
GCNA1 and gH2AX in ovarian sections (Fig. 6). Most oocytes in
both Casp9 þ/þ and / ovaries were at the late leptotene to
mid zygotene stages with heavy gH2AX staining at 16.5 dpc
(Fig. 6a–d), and progressed to the pachytene stage with ﬁne
gH2AX foci at 18.5 dpc (Fig.6e–h). At 19.5 dpc, the number of
GCNA1-positive cells were visibly greater in Casp9 / ovaries
than Casp9 þ/þ ovaries (Fig. 6i–l). Many GCNA1-positive cells
were gH2AX-negative, a characteristic of the late meiotic pro-
phase, in both genotypes of ovaries. Thus, the oocytes appeared to
have progressed through the meiotic prophase and were accu-
mulated at the end of the meiotic prophase in Casp9 / ovaries.
Expression and localization of IAPs in ovaries
In the presence of constitutively activated caspases, oocytes
must be protected from apoptotic demise. We speculated that oneFig. 5. The total number of GCNA1-positive cells in Casp9 / ovaries compared to Ca
mean7s.e.m. The number of examined ovaries is shown in parentheses. n denotes sig
signiﬁcant difference (Po0.001) between the rate of oocyte loss in Casp9 þ/þ and or more of endogenous Inhibitor of Apoptosis Proteins (IAPs) may
have counterbalanced the activity of caspases and allowed for the
survival of oocytes. We conﬁrmed that cIAP1, cIAP2, XIAP, and
Survivin were expressed in Msh5 þ/þ ovaries at 18.5 dpc by RT-
PCR (not shown). IF staining showed that XIAP was abundant in
the cytoplasm of almost all oocytes in both Msh5 þ/þ and /
ovaries at 16.5 dpc (Fig. 7a and b). The staining for XIAP was
intensiﬁed and occasionally seen in the nuclei of some oocytes in
Msh5 þ/þ ovaries at later stages (Fig. 7c). On the other hand, the
intensity of IF staining was considerably reduced in Msh5 /
ovaries at 19.5 dpc (Fig. 7d).
Localization of cleaved PARP1 in ovaries
Since the activation of caspases is constitutive and cannot be
used for indicating the oocytes undergoing apoptotic demise, we
searched for their downstream apoptotic markers. TUNEL detects
DNA fragmentation, one of the ﬁnal apoptotic events, and is often
used as an apoptosis indicator. However, TUNEL does not corre-
spond to oocyte demise during meiotic prophase progression for
unknown reason (De Felici et al., 2008; Ghafari et al., 2007;
Pepling and Spradling, 2001) (our unpublished observation). On
the other hand, the cleavage of PARP1 has been shown to be
associated with oocyte elimination during cyst breakdown in
neonatal ovaries (Pepling and Spradling, 2001). Hence, we exam-
ined the localization of cleaved PARP1 (cPARP1) with the antibody
which recognized its 24 kDa fragment in ovarian sections. The IF
staining was restricted to the nuclei of a few oocytes per section
from both Msh5 þ/þ and / ovaries at 16.5–18.5 dpc (not
shown). The frequency of cPARP1-positive cells increased inMsh5
þ/þ ovaries and more so in Msh5 / ovaries at 19.5 dpc
(Fig. 8). We performed immunoblot of ovarian homogenate with
an antibody against the full-form of PARP1. The cleavage of PARP1
was detectable at all stages and no difference was found between
Msh5 þ/þ and / ovaries (not shown).
Frequency of cPARP1-positive oocytes
To test whether the cleavage of PARP1 represents the apoptosis
execution in oocytes, we compared the frequency of cPARP1-positive
oocytes in Msh5 / and the control ovaries by double staining for
GCNA1 and cPARP1 in dissociated cell preparations. Under an epi-
ﬂuorescence microscope, more than 100 GCNA1-positive nuclei were
identiﬁed per ovary, and their staining for cPARP1 was recorded. Only
those with DAPI staining were considered to be oocyte nuclei.
Various staining patterns were observed in both Msh5 þ/þ andsp9 þ/þ ovaries at progressive developmental stages. A. Each value indicates the
niﬁcant difference (Po0.05) by student t-test. B. Regression analysis indicates a
/ ovaries.
Fig. 6. Distribution and meiotic stages of oocytes in Caps9 þ/þ (left) and / (right) ovaries at progressive developmental stages. IF staining for GCNA1 (green) and
gH2AX (red) was merged with DAPI counterstaining (blue). a, c, e, g, i, k. At a low magniﬁcation with overlays. b, d, f, h, j, l. At a higher magniﬁcation with overlays,
followed by red and green signals alone underneath. n indicates the same site of a section in the two corresponding pictures. Bar 50 and 25 mm at low and high
magniﬁcations, respectively. a–d. At 16.5 dpc. Numerous germ cells were heavily labeled for gH2AX, indicating that the vast majority of oocytes are at the leptotene to
zygotene stages. Some GCNA1-positive cells (arrows) are gH2AX-negative, indicating that DSBs have not yet been formed in these cells. e–h. At 18.5 dpc. A smaller number
of GCNA1-positive cells are seen, most of which show ﬁne gH2AX foci, indicating that they have progressed to the late zygotene to early pachytene stages. i and j. Caps9
þ/þ ovary at 19.5 dpc. The number of GCNA1-positive cells has further decreased. Most oocytes have no or few gH2AX foci, characteristics of the late meiotic prophase
except for a few (arrows) with many gH2AX foci. k and l. Caps9 / ovary at 19.5 dpc. For comparison with the Caps9 þ/þ ovary, a greater number of GCNA1-positive
cells are seen. Their majority show many ﬁne gH2AX foci, characteristics of the late zygotene to early pachytene stages. Some oocytes (arrowheads) are gH2AX-negative,
characteristic of the late meiotic prophase.
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for cPARP1. Some oocytes had typical nuclear sizes and were fully
labeled for cPARP1 (Fig. 9Aa and b) whereas some nuclei were
partially covered by GCNA1 staining and fully covered by cPARP
staining (Fig. 9Ac). The dominant staining pattern was the GCNA1-
positive nuclei with intense cPARP1 staining but of much smallersizes compared to typical oocyte nuclei (Fig. 9Ad). Many cells were
found to be negative for GCNA1 and positive for cPARP1 (Fig. 9Ae).
Since these cell types could not be identiﬁed, they were not included
for counting. As summarized in Fig. 9B, the percentage of cPARP1-
positive oocytes was about 10% in the ovaries of all three genotypes
at 16.5–19.5 dpc, and increased to about 20% in bothMsh5 þ/þ and
Fig. 7. IF localization of XIAP inMsh5 þ/þ and / ovaries at 16.5 and 19.5 dpc. IF staining for XIAP (red) and GCNA1 (green) is merged with DAPI counterstaining in a–d,
followed by green and red signals alone. Bar 40 mm. a. Msh5 þ/þ ovary at 16.5 dpc. XIAP staining is seen in the cytoplasm of almost all oocytes. b. Msh5 / ovary at
16.5 dpc. Similar to the Msh5 þ/þ ovary (a). c. Msh5 þ/þ ovary at 19.5 dpc. XIAP staining in the cytoplasm is more irregular compared to the ovary at 16.5 dpc. d. Msh5
/ ovary at 19.5 dpc. XIAP staining in the cytoplasm is less intense compared to the Msh5 þ/þ ovary (c) or the Msh / ovary at 16.5 dpc (b).
Fig. 8. IF localization of cleaved PARP1 in Msh5 þ/þ and / ovaries at 19.5 dpc. IF staining for the 24 kDa fragment of PARP1 (red) and GCNA1 (green) is merged with
DAPI counterstaining (blue) in a–e, followed by green and red signals alone. Bar 160 mm in a, c and 40 mm in b, d, e. a and b. Msh5 þ/þ ovary. The arterisk indicates the
same site of the section. One oocyte (arrow) is double labeled for GCNA1 and cPARP1. c–e. Msh5 / ovary. The single and double asterisks indicate the same sites of the
section. A few oocytes (arrows) are double labeled for GCNA1 and cPARP1.
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It decreased to the basal line in Msh5 þ/þ and þ/ ovaries but
remained signiﬁcantly higher (Po0.05) in Msh5 / ovaries at
21.5 dpc. Thus, the frequency of c PARP1-positive oocyte nuclei
increased preceding the loss of all oocytes in Msh5 / ovaries.Discussions
The meiotic prophase in the oocyte is a critical period for female
fertility. Proper pairing and recombination between homologous
chromosomes determines the success in chromosome segregation
Fig. 9. Frequency of cPARP1-positive germ cells in the dissociated cell preparations from Msh5 þ/þ , þ/ , and / ovaries at progressive developmental stages. A. Variable
patterns of IF staining for cPARP1 (red) and GCNA1 (green) merged with DAPI counterstaining (blue), followed by green and red signals alone except that DAPI signals alone are also
shown in c. Bar 40 mm. a. The entire nucleus of one oocyte is labeled for cPARP1. GCNA1 staining indicates condensed chromosomes, typical of the mid meiotic prophase. Another
oocyte nearby is negative for cPARP1. b. The entire nucleus of one oocyte is labeled for cPARP1 while other oocyte nuclei are negative. c. GCNA1 staining is seen only in half of the
nucleus while cPARP staining covers the entire nucleus. d. The nucleus labeled for both GCNA1 and cPARP1 is considerably smaller than the typical oocyte nucleus nearby, which is
cPARP1-negative. B. Percentage of cPARP1-positive cells among GCNA1-positive cells. Each column indicates the mean7s.e.m. The number of examined ovaries is given on the top
of each column. nn and n indicate statistical differences from either Msh5 þ/þ or Msh5 þ/ ovaries by ANOVA (Po0.01 and 0.05, respectively).
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ment. Furthermore, a major elimination of oocytes occurs during
this period to limit the oocyte reserve for reproduction. If selection
takes place in oocyte elimination, this event also inﬂuences the
quality of oocytes in reserve. Despite its importance, neither the
cause nor the regulatory mechanism of physiological oocyte
elimination is well understood. Our current studies show that the
mitochondrial apoptotic pathway mediated by caspase 9 plays arole in oocyte demise during meiotic prophase progression. How-
ever, caspase 9, and caspase 7 to a lesser extent, are constitutively
activated in all oocytes and, therefore, do not immediately lead to
oocyte demise. We speculate that the endogenous apoptosis
inhibitors, particularly XIAP, may counterbalance the activity of
caspases and allow for the oocytes to survive. We further show
that the cleavage of PARP1 is, so far, the best indicator of apoptotic
execution in the oocytes during meiotic prophase progression.
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Our results indicate that caspase 9 is constitutively activated
in the oocytes during meiotic prophase progression as demon-
strated by IF staining of cleaved caspase 9. Consequently, the fate
of oocytes must be regulated in its downstream mechanisms.
Caspase 7 appears to be a stronger candidate of the effector
caspase downstream of caspase 9 than caspase 3. This conclusion
is consistent with the report that a caspase 3 null mutation does
not affect the number of follicles in neonatal ovaries (Matikainen
et al., 2001). However, while immunoblot of entire ovaries
demonstrated a robust increase in the activation of caspase 9 with
a peak at 18.5 dpc, none of the effector caspases showed activa-
tion levels comparable to that of caspase 9. We speculate that the
proteolytic activity of caspase 9 was suppressed by cIAPs and,
therefore, its downstream caspase activation was not as robust as
caspase 9 activation.
Essential role of caspase 9 in the elimination of oocytes
A role of caspase 2 and mitochondrial anti-apoptotic compo-
nents Bcl-2 and Bcl-x in the regulation of oocyte population in
fetal life has been previously reported (Flaws et al., 2001; Ratts
et al., 1995; Rucker et al., 2000). However, no evidence was
provided for their roles speciﬁcally in the elimination of oocytes
during meiotic prophase progression. We have revealed that a
mitochondrial pro-apoptotic component Bax is required for the
elimination of oogonia but not that of oocytes (Alton and Taketo,
2007). In the present study, we have shown that the mitochon-
drial apoptotic pathway mediated by caspase 9 is indeed required
for the elimination of oocytes in the meiotic prophase. The total
number of germ cells did not differ with or without the caspase
9 deﬁciency at 16.5 or 18.5 dpc, but reached signiﬁcantly higher
levels with caspase 9 deﬁciency at 19.5 dpc, at which stage the
majority of oocytes had completed homologous chromosome
pairing and recombination. Furthermore, the rate of oocyte loss
was much slower in Casp9 / ovaries than in Casp9 þ/þ or
þ/ ovaries from 16.5 dpc to 19.5 dpc. Therefore, we speculate
that caspase 9 is particularly important for the elimination of
oocytes with meiotic errors such as asynapsis. It will be interesting
to examine the surviving oocytes in Casp9 / ovaries at later
stages. Unfortunately, most Casp9 / progeny die perinatally.
A conditional knockout of caspase 9 in the oocyte would be useful
for further studies.
Possible protection of oocytes by XIAP from apoptotic elimination
In the presence of constitutively active caspases, oocytes must
be protected from apoptotic elimination to survive. Such protec-
tion may be provided by cIAPs, endogenous apoptosis inhibitors.
Eight cIAP family proteins have been identiﬁed in mammals.
Of these, cIAP1 (HIAP), cIAP2 (HIAP2), and XIAP are known to bind
and potently inhibit caspases 3, 7, and 9, but not caspase 1, 6, or 8
(Deveraux et al., 1997; Deveraux et al., 1998). Furthermore, these
cIAP1s possess an E3 ubiquitin ligase activity, suggesting that the
degradation of caspases may be another mechanism by which
cIAPs suppress apoptosis (Conze et al., 2005; Vaux and Silke,
2005). In the present study, we conﬁrmed that cIAP1, cIAP2, and
XIAP were transcribed in Msh5 þ/þ ovaries. Furthermore, XIAP,
known to be the most potent cIAP, was localized to the cytoplasm
of almost all oocytes in ovaries at 16.5 dpc and decreased in IF
staining intensity, particularly in Msh5 / ovaries, at 19.5–
20.5 dpc. This window may have allowed for the apoptotic
elimination of oocytes with meiotic errors. Alternatively, meiotic
errors may result in the reduction of XIAP levels and consequent
apoptotic elimination. A similar role of XIAP has been suggestedfor the survival of granulosa and Sertoli cells, in which caspases
are constitutively activated (Johnson et al., 2008; Li et al., 1998).
On the other hand, an Xiap / mutant mouse has been reported
to be healthy and fertile (Harlin et al., 2001); however, the
redundancy among cIAP1s is a concern. Oocyte-speciﬁc over-
expression of XIAP may address the role of XIAP in oocyte
elimination.Nuclear localization of cleaved PARP1 captures the oocytes
undergoing apoptotic demise
In contrast to the ubiquitous presence of cleaved caspases
in oocytes, cPARP1 was localized to the nuclei of a small number
of oocytes in ovarian sections. In dissociated ovarian cells, the
percentage of cPARP1-positive oocytes was steady at around 10%
in the ovaries of all three genotypes and transiently increased in
Msh5 þ/þ and þ/ ovaries at 20.5 dpc. Ghafari et al. (2007) have
reported that 10–50% of oocytes are positive for cPARP1 at all
stages during meiotic prophase progression in normal mouse
ovaries. In our studies, however, 20% was the maximum fre-
quency of cPARP1-positive oocytes in the control ovaries. In
contrast, the percentage of cPARP1-positive oocytes in Msh5
/ ovaries increased to 60% at 20.5 dpc and remained higher
at 21.5 dpc. Since most oocytes were eliminated in Msh5 /
ovaries by 22.5 dpc, the high frequency of cPARP1 appeared to
precede the oocyte loss. Some cPARP1-positive nuclei had the size
and shape comparable to those of cPARP1-negative nuclei, indi-
cating that the cleavage of PARP1 is one of the earliest events in
the oocytes undergoing apoptotic demise. However, the majority
of nuclei labeled for both GCNA1 and cPARP1 were much smaller
in size than typical oocyte nuclei and many more nuclei were
positive for cPARP1 and negative for GCNA1. We speculate that
once an oocyte was committed to apoptotic elimination, its
nucleus rapidly became picnotic while GCNA1 was degraded.Summary
We have previously reported steady oocyte loss from 13.5 to
21.5 dpc in normal mouse ovaries (McClellan et al., 2003). Since a
caspase 9 deﬁciency did not inﬂuence the oocyte population up to
18.5 dpc, the early phase of oocyte elimination may not involve
the mitochondrial apoptotic pathway. The extrinsic apoptotic
pathway or autophagy may play a role in oocyte loss in this
phase. By contrast, the later phase of oocyte loss was prevented
and the total number of oocytes became signiﬁcantly greater in
Casp9 / ovaries at 19.5 dpc. On the other hand, the total
number of oocytes was signiﬁcantly decreased in Msh5 /
ovaries at 19.5 dpc. Furthermore, the percentage of cPARP1
oocytes in Msh5 / ovaries dramatically increased to higher
levels than the control ovaries at 20.5 and 21.5 dpc, soon before
complete loss of oocytes. These results suggest that the caspase
9-dependent apoptotic pathway operates speciﬁcally for the
elimination of oocytes with meiotic errors during a narrow
window between 18.5 and 21.5 dpc. Two major questions remain
to be addressed: what triggers the apoptotic execution of oocytes
in normal ovaries; and what inhibits the cIAP activity to allow for
oocyte demise.Funding
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